PRAX · Categories · Form 4

PRAX - SEC Form 4 insider transactions

Praxis Precision Medicines Inc. (PRAX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PRAX

• 86d
  Director Arbuckle Stuart A was granted 1,166 shares (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 86d
  Director Kindler Jeffrey B was granted 1,166 shares (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 114d
  Principal Accounting Officer Mastrocola Lauren covered exercise/tax liability with 344 shares, decreasing direct ownership by 2% to 13,446 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 114d
  Chief Operating Officer Sniecinski Megan covered exercise/tax liability with 885 shares, decreasing direct ownership by 3% to 28,530 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 114d
  General Counsel and Secretary Nemiroff Alex covered exercise/tax liability with 768 shares, decreasing direct ownership by 3% to 25,933 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 114d
  Chief Financial Officer Kelly Timothy Edwin covered exercise/tax liability with 943 shares, decreasing direct ownership by 3% to 31,046 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 115d
  Principal Accounting Officer Mastrocola Lauren was granted 3,750 shares and covered exercise/tax liability with 367 shares, increasing direct ownership by 33% to 13,790 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 115d
  Chief Operating Officer Sniecinski Megan was granted 9,625 shares and covered exercise/tax liability with 1,087 shares, increasing direct ownership by 41% to 29,415 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 115d
  General Counsel and Secretary Nemiroff Alex covered exercise/tax liability with 917 shares and was granted 6,875 shares, increasing direct ownership by 29% to 26,701 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 115d
  Chief Financial Officer Kelly Timothy Edwin was granted 8,800 shares and covered exercise/tax liability with 1,335 shares, increasing direct ownership by 30% to 31,989 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 115d
  Chief Executive Officer Souza Marcio was granted 27,640 shares and covered exercise/tax liability with 4,252 shares, increasing direct ownership by 44% to 76,890 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 118d
  Principal Accounting Officer Mastrocola Lauren covered exercise/tax liability with 35 shares, decreasing direct ownership by 0.34% to 10,407 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 118d
  General Counsel and Secretary Nemiroff Alex covered exercise/tax liability with 89 shares, decreasing direct ownership by 0.43% to 20,743 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 118d
  Chief Financial Officer Kelly Timothy Edwin covered exercise/tax liability with 139 shares, decreasing direct ownership by 0.56% to 24,524 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 118d
  Chief Executive Officer Souza Marcio covered exercise/tax liability with 405 shares, decreasing direct ownership by 0.75% to 53,502 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 127d
  Chief Executive Officer Souza Marcio gifted 400 shares (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 167d
  Chief Financial Officer Kelly Timothy Edwin was granted 384 shares, increasing direct ownership by 2% to 24,663 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 167d
  General Counsel and Secretary Nemiroff Alex exercised 25,130 shares at a strike of $73.76 and sold $4,852,256 worth of shares (25,130 units at $193.09) (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 167d
  Principal Accounting Officer Mastrocola Lauren exercised 13,600 shares at a strike of $61.12 and sold $2,612,244 worth of shares (13,600 units at $192.08) (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 202d
  SEC Form 4 filed by Large owner Adage Capital Management, L.P.

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 224d
  Director Mitchell Dean J exercised 12,251 shares at a strike of $39.51, increasing direct ownership by 245% to 17,251 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 314d
  SEC Form 4 filed by Director Mitchell Dean J

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 314d
  SEC Form 4 filed by Director Young William D

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 314d
  SEC Form 4 filed by Director Norden Gregory

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 314d
  SEC Form 4 filed by Director Desimone Jill

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 314d
  SEC Form 4 filed by Director Chodakewitz Jeffrey

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 314d
  SEC Form 4 filed by Director Cudkowicz Merit Ester

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 353d
  Chief Executive Officer Souza Marcio was granted 348 shares, increasing direct ownership by 0.65% to 53,907 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 353d
  Chief Financial Officer Kelly Timothy Edwin was granted 249 shares, increasing direct ownership by 1% to 24,279 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 447d
  General Counsel and Secretary Nemiroff Alex covered exercise/tax liability with 51 shares, decreasing direct ownership by 0.24% to 20,832 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 447d
  Principal Accounting Officer Mastrocola Lauren covered exercise/tax liability with 40 shares, decreasing direct ownership by 0.38% to 10,442 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 447d
  Chief Executive Officer Souza Marcio covered exercise/tax liability with 401 shares, decreasing direct ownership by 0.74% to 53,559 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 478d
  Principal Accounting Officer Mastrocola Lauren was granted 5,000 shares and covered exercise/tax liability with 390 shares, increasing direct ownership by 79% to 10,482 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 478d
  Chief Executive Officer Souza Marcio was granted 37,500 shares, increasing direct ownership by 228% to 53,960 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 478d
  Chief Financial Officer Kelly Timothy Edwin was granted 12,500 shares and covered exercise/tax liability with 676 shares, increasing direct ownership by 97% to 24,030 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 478d
  General Counsel and Secretary Nemiroff Alex covered exercise/tax liability with 579 shares and was granted 11,250 shares, increasing direct ownership by 104% to 20,883 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 484d
  Chief Executive Officer Souza Marcio covered exercise/tax liability with 434 shares, decreasing direct ownership by 3% to 16,460 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 484d
  Principal Accounting Officer Mastrocola Lauren covered exercise/tax liability with 35 shares, decreasing direct ownership by 0.59% to 5,872 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 484d
  General Counsel and Secretary Nemiroff Alex covered exercise/tax liability with 89 shares, decreasing direct ownership by 0.86% to 10,212 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 484d
  Chief Financial Officer Kelly Timothy Edwin covered exercise/tax liability with 139 shares, decreasing direct ownership by 1% to 12,206 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 534d
  Principal Accounting Officer Mastrocola Lauren was granted 294 shares, increasing direct ownership by 5% to 5,907 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 534d
  Chief Financial Officer Kelly Timothy Edwin was granted 205 shares, increasing direct ownership by 2% to 12,345 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 538d
  General Counsel and Secretary Nemiroff Alex exercised 7,583 shares at a strike of $56.94 and sold $660,827 worth of shares (8,239 units at $80.20), decreasing direct ownership by 6% to 10,301 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 538d
  Principal Accounting Officer Mastrocola Lauren exercised 4,374 shares at a strike of $56.94 and sold $424,318 worth of shares (5,188 units at $81.78), decreasing direct ownership by 13% to 5,613 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 645d
  SEC Form 4 filed by Chief Executive Officer Souza Marcio

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 645d
  General Counsel and Secretary Nemiroff Alex was granted 7,800 shares, increasing direct ownership by 247% to 10,957 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 645d
  Principal Accounting Officer Mastrocola Lauren was granted 4,500 shares, increasing direct ownership by 234% to 6,427 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 645d
  Chief Financial Officer Kelly Timothy Edwin was granted 7,800 shares, increasing direct ownership by 180% to 12,140 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 700d
  SEC Form 4 filed by Desimone Jill

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 700d
  SEC Form 4 filed by Mitchell Dean J

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 700d
  SEC Form 4 filed by Chodakewitz Jeffrey

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 700d
  SEC Form 4 filed by Cudkowicz Merit Ester

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 700d
  SEC Form 4 filed by Young William D

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 700d
  SEC Form 4 filed by Norden Gregory

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 717d
  Kelly Timothy Edwin was granted 606 shares, increasing direct ownership by 16% to 4,340 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 717d
  Souza Marcio was granted 1,718 shares, increasing direct ownership by 11% to 16,894 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 813d
  Mastrocola Lauren covered exercise/tax liability with 48 shares, decreasing direct ownership by 2% to 1,927 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 813d
  Souza Marcio covered exercise/tax liability with 271 shares, decreasing direct ownership by 2% to 15,176 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 813d
  Nemiroff Alex covered exercise/tax liability with 51 shares, decreasing direct ownership by 2% to 3,157 units (SEC Form 4)

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)
• 841d
  SEC Form 4 filed by Kelly Timothy Edwin

  4 - Praxis Precision Medicines, Inc. (0001689548) (Issuer)

Other PRAX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends